Total HIV DNA: a global marker of HIV persistence.

about

Development of sensitive ddPCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant forms

P2860

Q58128506-1F49EEE5-CD3C-4621-B056-74BE335F8B2A

P2860

Total HIV DNA: a global marker of HIV persistence.

Item

http://www.wikidata.org/entity/Q54242626

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Total HIV DNA: a global marker of HIV persistence.

@en

Total HIV DNA: a global marker of HIV persistence.

@nl

type

Item

label

Total HIV DNA: a global marker of HIV persistence.

@en

Total HIV DNA: a global marker of HIV persistence.

@nl

prefLabel

Total HIV DNA: a global marker of HIV persistence.

@en

Total HIV DNA: a global marker of HIV persistence.

@nl

P1476

Total HIV DNA: a global marker of HIV persistence.

@en

P2093

Véronique Avettand-Fenoël

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection

Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

HIV-DNA in the genital tract of women on long-term effective therapy is associated to residual viremia and previous AIDS-defining illnesses.

A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level.

Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers.

HIV-1 DNA predicts disease progression and post-treatment virological control.

HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy

Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy

P2888

s12977-018-0412-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S12977-018-0412-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christine Rouzioux

P5008

ScienceSource

P577

2018-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103148474

http://www.w3.org/2001/XMLSchema#string

P698

29615133

http://www.w3.org/2001/XMLSchema#string

P921

HIV

human immunodeficiency virus infectious disease

Retroviridae infectious disease

biomedical investigative technique

Añaw

P932

5883363

http://www.w3.org/2001/XMLSchema#string

Total HIV DNA: a global marker of HIV persistence.

about

P2860

P2860

Total HIV DNA: a global marker of HIV persistence.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932